The Government of Alberta has made Pluvicto, a new radiopharmaceutical treatment for advanced prostate cancer, available to Albertans in an effort to improve treatment access.

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The founders of Bugworks Research are attempting to bring to market a new class of antibiotics--a first in almost half a ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Hyperemesis gravidarum affects 3% of pregnancies, causing severe vomiting and dehydration. Experts explain the causes, ...

PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...

We came across a bullish thesis on Fresenius Medical Care AG (NYSE:FMS) on ValueInvestorsClub by mimval. In this article, we ...

For patients who need to take oral medication twice daily, Professor Al-Shamsi recommended scheduling doses at Iftar and ...

Nutritionist Sarah Di Lorenzo takes a deep dive into the supplement that promises to stop ageing in its tracks.

A study reveals the impact of anaesthetic gases such as desflurane on healthcare emissions and how to reduce their carbon ...

Researchers from Revolo Biotherapeutics Ltd. recently presented preclinical data for IRL-201104, a clinical-stage ...